Literature DB >> 11013687

Gliomatosis cerebri: disconnection of the cortical grey matter, demonstrated on PET scan.

P N Plowman1, C A Saunders, M N Maisey.   

Abstract

18-FDG and 11C methionine PET scans were performed on two patients with gliomatosis cerebri. The cortical grey matter was hypometabolic when compared with normal. The findings support the concept that the cerebral cortex becomes functionally disconnected in this disease owing to the infiltrative nature of the underlying tumour. This may account for the high incidence of dementia in the course of this disease. In one of the cases described here, there was clear evidence of progression from a discrete tumour mass of glioma to gliomatosis cerebri and this progression argues against the WHO classification of this disorder separately from glioma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 11013687     DOI: 10.1080/02688699845069

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  4 in total

1.  Juvenile parkinsonism as an initial manifestation of gliomatosis cerebri.

Authors:  Wooyoung Jang; Seung Hyun Ha; Shin Kwang Khang; Juhan Kim; Seung Hyun Kim; Hee-Jin Kim
Journal:  J Neurol       Date:  2013-10-25       Impact factor: 4.849

2.  Insufficiency of positron emission tomography and magnetic resonance spectroscopy in the diagnosis of intravascular lymphoma of the central nervous system.

Authors:  Nobuyuki Kawai; Masaki Okada; Reiji Haba; Yuka Yamamoto; Takashi Tamiya
Journal:  Case Rep Oncol       Date:  2012-07-03

Review 3.  Gliomatosis Cerebri: Current Understanding and Controversies.

Authors:  Surabhi Ranjan; Katherine E Warren
Journal:  Front Oncol       Date:  2017-08-07       Impact factor: 6.244

Review 4.  18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma.

Authors:  Nobuyuki Kawai; Keisuke Miyake; Yuka Yamamoto; Yoshihiro Nishiyama; Takashi Tamiya
Journal:  Biomed Res Int       Date:  2013-06-17       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.